Chairmans Address to Shareholders
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Response to ASX Query re Share Price & Volume
- Placement
- Pharmaceutical Treatment Division Update
- Pharmaceutical focus in 2008
- Eastland to merge Victorian and NSW operations
Later from Arovella Therapeutics
- Acquires 50% of Aust. Sterile Barrier products manufacturer
- Associate secures another UK Medical Distributor
- Commitments Test Entity - Fourth Quarter Report
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics